Invesco’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.7M Sell
419,411
-38,193
-8% -$2.23M ﹤0.01% 1368
2025
Q4
$27.2M Sell
457,604
-86,792
-16% -$4.73M ﹤0.01% 1307
2025
Q3
$29.5M Sell
544,396
-74,439
-12% -$4.26M ﹤0.01% 1287
2025
Q2
$34M Buy
618,835
+117,617
+23% +$6.93M 0.01% 1212
2025
Q1
$35.4M Sell
501,218
-3,563
-0.7% -$240K 0.01% 1166
2024
Q4
$33.2M Sell
504,781
-38,291
-7% -$2.56M 0.01% 1235
2024
Q3
$38.2M Buy
543,072
+5,622
+1% +$470K 0.01% 1154
2024
Q2
$44.2M Buy
537,450
+123,433
+30% +$10.3M 0.01% 1062
2024
Q1
$36.2M Buy
414,017
+17,912
+5% +$1.6M 0.01% 1180
2023
Q4
$38.2M Sell
396,105
-52,512
-12% -$4.65M 0.01% 1122
2023
Q3
$39.7M Sell
448,617
-535,553
-54% -$47.7M 0.01% 1048
2023
Q2
$85.3M Sell
984,170
-832,840
-46% -$78.4M 0.02% 766
2023
Q1
$177M Sell
1,817,010
-18,051
-1% -$1.87M 0.05% 523
2022
Q4
$190M Buy
1,835,061
+1,430,955
+354% +$134M 0.06% 485
2022
Q3
$34.3M Buy
404,106
+107,568
+36% +$9.58M 0.01% 1048
2022
Q2
$24.6M Buy
296,538
+6,849
+2% +$545K 0.01% 1249
2022
Q1
$22.3M Buy
289,689
+6,266
+2% +$524K 0.01% 1442
2021
Q4
$25M Sell
283,423
-6,072
-2% -$501K 0.01% 1412
2021
Q3
$22.4M Buy
289,495
+13,676
+5% +$1.08M 0.01% 1493
2021
Q2
$23M Sell
275,819
-129,362
-32% -$10.3M 0.01% 1530
2021
Q1
$30.6M Buy
405,181
+86,222
+27% +$7.04M 0.01% 1300
2020
Q4
$28M Sell
318,959
-267,701
-46% -$21.2M 0.01% 1263
2020
Q3
$44.6M Buy
586,660
+45,748
+8% +$4.63M 0.02% 983
2020
Q2
$66.7M Buy
540,912
+12,772
+2% +$1.27M 0.02% 781
2020
Q1
$44.6M Sell
528,140
-91,163
-15% -$7.85M 0.02% 854
2019
Q4
$52.4M Sell
619,303
-1,628,859
-72% -$123M 0.02% 999
2019
Q3
$152M Sell
2,248,162
-597,674
-21% -$46M 0.04% 512
2019
Q2
$244M Sell
2,845,836
-622,286
-18% -$53.2M 0.06% 361
2019
Q1
$308M Buy
3,468,122
+153,073
+5% +$14.2M 0.1% 227
2018
Q4
$282M Buy
3,315,049
+17,892
+0.5% +$1.7M 0.11% 216
2018
Q3
$320M Sell
3,297,157
-11,306
-0.3% -$1.13M 0.1% 215
2018
Q2
$312M Sell
3,308,463
-883,153
-21% -$77.3M 0.1% 215
2018
Q1
$340M Sell
4,191,616
-322,025
-7% -$27.6M 0.13% 187
2017
Q4
$402M Buy
4,513,641
+24,250
+0.5% +$2.11M 0.15% 162
2017
Q3
$418M Buy
4,489,391
+285,475
+7% +$25.2M 0.15% 153
2017
Q2
$382M Buy
4,203,916
+570,718
+16% +$51.9M 0.12% 191
2017
Q1
$319M Buy
3,633,198
+245,430
+7% +$21.8M 0.1% 219
2016
Q4
$281M Buy
3,387,768
+328,400
+11% +$28.2M 0.09% 245
2016
Q3
$283M Buy
3,059,368
+701,506
+30% +$66.1M 0.1% 233
2016
Q2
$183M Sell
2,357,862
-106,783
-4% -$9.08M 0.07% 312
2016
Q1
$203M Sell
2,464,645
-175,658
-7% -$14.3M 0.08% 278
2015
Q4
$277M Buy
2,640,303
+175,626
+7% +$18.3M 0.11% 209
2015
Q3
$260M Buy
2,464,677
+1,326,148
+116% +$177M 0.11% 215
2015
Q2
$156M Buy
1,138,529
+249,445
+28% +$30.9M 0.06% 372
2015
Q1
$111M Buy
889,084
+847
+0.1% +$89.7K 0.04% 478
2014
Q4
$80.3M Buy
888,237
+387,805
+77% +$32.2M 0.03% 590
2014
Q3
$36.1M Sell
500,432
-630
-0.1% -$41.4K 0.01% 946
2014
Q2
$31.2M Sell
501,062
-734,907
-59% -$44.4M 0.01% 1026
2014
Q1
$84.3M Sell
1,235,969
-639,405
-34% -$47.1M 0.03% 556
2013
Q4
$132M Sell
1,875,374
-125,663
-6% -$8.53M 0.05% 426
2013
Q3
$144M Sell
2,001,037
-130,116
-6% -$8.65M 0.06% 360
2013
Q2
$119M Buy
+2,131,153
New +$133M 0.06% 381

Other funds holding BMRN